Intraconazole: An effective oral antifungal for onychomycosis

International Journal of Dermatology

Volumn 40, Issue 1, 2001, Pages 1-5

  Jain, Sanjeev ^a,b   Sehgal, Virendra N ^a,b  

^a Skin Care Clinic   (India)

^b Sehgal Nursing Home   (India)

Author keywords

[No Author keywords available]

Indexed keywords

ALBUMIN; CYTOCHROME P450; ITRACONAZOLE; PLACEBO; ANTIFUNGAL AGENT;

ABDOMINAL DISCOMFORT; ANTIFUNGAL ACTIVITY; CLINICAL TRIAL; DERMATOPHYTE; DOSE RESPONSE; DRUG ABSORPTION; DRUG BIOAVAILABILITY; DRUG BLOOD LEVEL; DRUG DISTRIBUTION; DRUG EFFICACY; DRUG ELIMINATION; DRUG MECHANISM; DRUG METABOLISM; DRUG PULSE THERAPY; ENZYME INHIBITION; EXPERIMENTAL MODEL; FUNGUS; HUMAN; KIDNEY FAILURE; LIVER DISEASE; LIVER FAILURE; META ANALYSIS; NAIL; NONHUMAN; ONYCHOMYCOSIS; REVIEW; STOMACH PH; STRUCTURE ACTIVITY RELATION; TARGET ORGAN; ARTHRODERMA; DRUG ANTAGONISM; DRUG EFFECT; ENZYMOLOGY; METABOLISM; MICROBIOLOGY; ORAL DRUG ADMINISTRATION;

ADMINISTRATION, ORAL; ANTIFUNGAL AGENTS; ARTHRODERMATACEAE; CYTOCHROME P-450 ENZYME SYSTEM; HUMANS; ITRACONAZOLE; ONYCHOMYCOSIS;

EID: 0034745350     PISSN: 00119059     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-4362.2001.01039.x     Document Type: Review

References (51)

1. Antimycotic azoles. Synthesis and anti-fungal properties of a series of novel triazol-3-ones
2. Biochemical basis for the activity and selectivity of oral anti-fungals
3. The triazole anti-fungal agents. A review of itraconazole and fluconazole
4. Biochemical approaches to the selective anti-fungal activity. Focus on azole anti-fungals
5. The in vitro anti-fungal spectrum of itraconazole
6. Fungicidal versus fungi-static activity of terbinafine and itraconazole: An in vitro comparison
7. Current management of onychomycosis
8. Oral, topical and parenteral anti-fungal treatment with itraconazole in normal and immuno-compromised animals
9. Activity of orally, topically, and parenterally administered itraconazole in the treatment of superficial and deep mycosis: Animal models
10. Antifungal activity of itraconazole and terbinafine in human stratum corneum: A comparative study
11. The effects of food and dose on the oral systemic availability of itraconazole in healthy subjects
12. The plasma protein binding of itraconazole and its distribution in blood
13. Pharmacokinetic profile of orally administered itraconazole in human skin
14. Itraconazole penetrates the nail via the nail matrix and the nail bed. An investigation in onychomycosis
15. Post treatment itraconazole levels in the nail
16. Anti-fungal pulse therapy for onychomycosis
17. The pharmacokinetics of itraconazole in animals and man: An overview
18. The clinical pharmacokinetics of itraconazole: An overview
19. Pharmacokinetics of itraconazole in renal dysfunction
20. Pharmacokinetics of itraconazole in cirrhotic patients
21. An evaluation of itraconazole in the management of onychomycosis
22. Itraconazole in the management of chronic dermatophytosis
23. Efficacy and safety of itraconazole in the long-term treatment of onychomycosis
24. Itraconazole in onychomycosis: Open and double blind studies
25. Itraconazole in dermatophyte infections: Clinical experience in Italy
26. Treatment of onychomycosis with itraconazole
27. Open randomized comparison of itraconazole versus terbinafine in onychomycosis
28. New approaches to the treatment of onychomycosis
29. The use of itraconazole in onychomycosis
30. Double blind, randomized comparison of itraconazole capsules vs placebo in the treatment of toenail onychomycosis
31. Long term results of patients with onychomycosis treated with itraconazole
32. A double blind randomized study comparing itraconazole pulse therapy with continuous dosing for the treatment of toenail onychomycosis
33. Pulse therapy with one-week itraconazole monthly for three or four months in the treatment of onychomycosis
34. European experiences with itraconazole pulse therapy in the treatment of toenail onychomycosis
35. Antifungal pulse therapy in toenail onychomycosis. Austrian experience
36. Itraconazole pulse therapy for the treatment of fingernail onychomycosis
37. Itraconazole in the treatment of onychomycosis: An open, multi-centre trial to investigate the efficacy and safety of itraconazole pulse therapy
38. Effect of itraconazole in the treatment of onychomycosis of toenails. A randomized double-blind trial comparing continuous treatment with pulse therapy
39. Effect of itraconazole intermittent therapy in the treatment of onychomycosis of fingernails. A randomized, double-blind comparison with placebo
40. Itraconazole in the treatment of onychomycosis: An open randomized trial to evaluate the efficacy and tolerability of three or four months intermittent therapy with itraconazole
41. Clinical expert summary on itraconazole for the treatment of onychomycosis with a shortened regime of 200 mg b.i.d. × 7 day/month for 2-3 months
42. Efficacy and safety of itraconazole 1 week pulse therapy in the treatment of onychomycosis: An open German multicentre trial
43. International therapy with itraconazole in onychomycosis: An update
44. Therapeutic efficacy of intermittent pulse therapy with itraconazole in onychomycosis: A Chinese multicentre trial
45. Intraconazole on onychomycosis: Intermittent dose schedule
46. Small dose itraconazole pulse therapy in the treatment of onychomycosis
47. A multi-center, placebo controlled, double-blind study of intermittent therapy with itraconazole for the treatment of onychomycosis of the fingernail
48. Itraconazole therapy is effective for pedal onychomycosis caused by some non-dermatophyte molds and in mixed infection with dermatophytes and molds: A multi-center study with 36 patients
49. Long term results of patients with onychomycosis treated with itraconazole
50. Itraconazole in the treatment of onychomycosis: An open randomized trial to evaluate the efficacy and tolerability of intermittent therapy with itraconazole
51. Efficacy and tolerability of itraconazole in patients with fingernail onychomycosis: A 6 week pilot study